GlcCer (d18:1/18:0)
GlcCer (d18:1/18:0) (C18 Glucosyl (β) ceramide (d18:1/18:0) ) is a glycosphingolipid. GlcCer (d18:1/18:0) is promising for research of Parkinson disease and dementia with Lewy bodies[1].
Product Specifications
CAS Number
[95119-86-1]
Product Name Alternative
C18 Glucosyl (β) ceramide (d18:1/18:0) ; D-glucosyl-β-1,1' N-stearoyl-D-erythro-sphingosine
UNSPSC
12352005
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Purity
99.93
Solubility
DMSO : 2.5 mg/mL (ultrasonic)
Smiles
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(CCCCCCCCCCCCCCCCC)=O)CO[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO
Molecular Formula
C42H81NO8
Molecular Weight
728.09
References & Citations
[1]Lerche S, et al. CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants. NPJ Parkinsons Dis. 2024 Oct 24;10 (1) :198.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
135141-FITC 100 µL
USF2 (Upstream Stimulatory Factor 2, Class B Basic Helix-loop-helix Protein 12, bHLHb12, FOS-interacting Protein, FIP, Major Late Transcription Factor 2, Upstream Transcription Factor 2) (FITC)
Ask
View Details 